Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
Division of Applied Life Science, Research Institute of Life Sciences, Gyeongsang National University, Jinju 52828, Republic of Korea.
J Microbiol Biotechnol. 2020 Oct 28;30(10):1488-1494. doi: 10.4014/jmb.2007.07033.
Rho guanine nucleotide dissociation inhibitor 1 (RhoGDI1) plays important roles in numerous cellular processes, including cell motility, adhesion, and proliferation, by regulating the activity of Rho GTPases. Its expression is altered in various human cancers and is associated with malignant progression. Here, we show that RhoGDI1 interacts with Cullin 3 (CUL3), a scaffold protein for E3 ubiquitin ligase complexes. Ectopic expression of CUL3 increases the ubiquitination of RhoGDI1. Furthermore, potassium channel tetramerization domain containing 5 (KCTD5) also binds to RhoGDI1 and increases its interaction with CUL3. Ectopic expression of KCTD5 increases the ubiquitination of RhoGDI1, whereas its knockdown by RNA interference has the opposite effect. Depletion of KCTD5 or expression of dominant-negative CUL3 (DN-CUL3) enhances the stability of RhoGDI1. Our findings reveal a previously unknown mechanism for controlling RhoGDI1 degradation that involves a CUL3/KCTD5 ubiquitin ligase complex.
Rho 鸟嘌呤核苷酸解离抑制剂 1(RhoGDI1)通过调节 Rho GTPases 的活性,在细胞运动、黏附和增殖等多种细胞过程中发挥重要作用。其表达在各种人类癌症中发生改变,并与恶性进展相关。在这里,我们显示 RhoGDI1 与 Cullin 3(CUL3)相互作用,CUL3 是 E3 泛素连接酶复合物的支架蛋白。CUL3 的异位表达增加了 RhoGDI1 的泛素化。此外,钾通道四聚化结构域包含 5(KCTD5)也与 RhoGDI1 结合,并增加其与 CUL3 的相互作用。KCTD5 的异位表达增加了 RhoGDI1 的泛素化,而其 RNA 干扰的敲低则产生相反的效果。KCTD5 的耗竭或显性负性 CUL3(DN-CUL3)的表达增强了 RhoGDI1 的稳定性。我们的发现揭示了一个以前未知的控制 RhoGDI1 降解的机制,该机制涉及 CUL3/KCTD5 泛素连接酶复合物。